University of Texas MD Anderson Cancer Center-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2021

  1. Upfront admixing antibodies and EGFR inhibitors preempts sequential treatments in lung cancer models

    EMBO Molecular Medicine, Vol. 13, Núm. 4